Zobrazeno 1 - 7
of 7
pro vyhledávání: '"J. H. Gunkel"'
Autor:
M. Shwer, K. P. Van Meurs, A. Lotze, S. Keeney, R. Cicco, J. McGowan, S. Denson, G. Knight, A. Thompson, W. Engle, K. B. Al-Mateen, R. Baker, E. Rider, P. Riedel, J. Gonzalez, C. Dothey, J. Sparks, E. Stork, S. St. Charles, G. Waterkotte, D. Hsiao, D. Kays, D. J. Rawlings, J. Ferlauto, D. Purohit, M. Keszler, D. Marsh, R. Miller, S. Pearlman, M. Magoon, J. Fasules, D. Stewart, W. Kanto, M. Maurer, J. H. Gunkel, M. Fernandes, H. Feick, E. M. Zola, M. Antunes, B. R. Mitchell, D. I. Bulas, R. A. Shalwitz, T. Weber, L. Parton, D. Sprague, B. Patel, J. Bhatia, M. Rodriguez, L. Salter, F. Murphey, W. Drummond, J. Gerdes
Publikováno v:
The Journal of Pediatrics. 132:40-47
Objective: The purpose of this study was to determine whether surfactant (beractant) administration to term newborns in respiratory failure and at risk for requiring extracorporeal membrane oxygenation (ECMO) treatment would significantly reduce the
Surfactant Therapy and Intracranial Hemorrhage: Review of the Literature and Results of New Analyses
Autor:
P. L. C. Banks, J. H. Gunkel
Publikováno v:
Pediatrics. 92:775-786
Background and objective. Surfactant replacement is a powerful therapy for newborns with respiratory distress syndrome, but limited observations suggest that alterations of cerebral blood flow can accompany the use of several available surfactants. A
Autor:
J H Gunkel, B R Mitchell, N G DeMarco, A M Overbach, B T Nagle, E M Zola, A J Gold, G A Henwood
Publikováno v:
Pediatrics. 91:546-551
From September 1989 through July 1991, before commercial availability, Survanta (beractant intratracheal suspension), a modified bovine-derived surfactant used for prevention and treatment of neonatal respiratory distress syndrome, was made available
Publikováno v:
The Journal of pediatrics. 132(1)
The purpose of this study was to determine whether surfactant (beractant) administration to term newborns in respiratory failure and at risk for requiring extracorporeal membrane oxygenation (ECMO) treatment would significantly reduce the incidence o
Surfactant therapy and intracranial hemorrhage: review of the literature and results of new analyses
Autor:
J H, Gunkel, P L, Banks
Publikováno v:
Pediatrics. 92(6)
Surfactant replacement is a powerful therapy for newborns with respiratory distress syndrome, but limited observations suggest that alterations of cerebral blood flow can accompany the use of several available surfactants. An early European multicent
Autor:
E M, Zola, A M, Overbach, J H, Gunkel, B R, Mitchell, B T, Nagle, N G, DeMarco, G A, Henwood, A J, Gold
Publikováno v:
Pediatrics. 91(3)
From September 1989 through July 1991, before commercial availability, Survanta (beractant intratracheal suspension), a modified bovine-derived surfactant used for prevention and treatment of neonatal respiratory distress syndrome, was made available
Autor:
R E, Hoekstra, J C, Jackson, T F, Myers, I D, Frantz, M E, Stern, W F, Powers, M, Maurer, J R, Raye, S T, Carrier, J H, Gunkel
Publikováno v:
Pediatrics. 88(1)
To determine whether multiple doses of bovine surfactant would improve neonatal mortality in very premature neonates, we conducted two multicenter controlled trials under identical protocols; the results were combined for analysis. Four hundred and t